16:06 , Mar 16, 2017 |  BC Innovations  |  Emerging Company Profile

More needles, less haystack

Companies developing blood-based diagnostics for cancer inevitably grapple with the challenge of too little cancer-related genetic material in patient samples to make reliable diagnoses. Liquid biopsy newco Freenome Inc. is developing tests for early stage...
07:00 , Aug 8, 2011 |  BC Week In Review  |  Company News

Ariadne Genomics, Hadasit deal

Ariadne and Hadasit's BioMarCare Technologies Ltd. subsidiary partnered to co-develop a diagnostic to predict patient response to metastatic colorectal cancer treatment. BioMarCare will develop the diagnostic, while both companies will be responsible for clinical testing....